The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis
Authors:
Open Access
- 14 May 2022
- journal article
- review article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 22 (1) , 1-16
Abstract
Background: Some patients with chronic coronary syndromes undergo invasive procedures but the efficacy of such interventions remains to be robustly established by randomised sham-controlled trials (RCTs). Purpose: To determine the sham effect in patients with chronic coronary syndromes enrolled in RCTs by performing a systematic review and meta-analysis. Methods: In April 2022, we performed a literature search for published patient-blind RCTs (CENTRAL, MEDLINE®, PsycINFO, and reference lists) with sham procedures, reporting the pre-post effects in the invasive sham arm among patients with Canadian cardiovascular society (CCS) angina or angina equivalents. Results: 16 RCTs were included with 546 patients in the sham arm. Pooled results showed that sham interventions were associated with: improvement of 7% (95% CI 2–11%; I2 = 0%) in exercise time; decrease of 0.78 (95% CI − 1.10 to − 0.47; I2 = 75%) in CCS angina class; decrease of 53% (95% CI 24–71%; I2 = 96%) and 25% (95% CI 20–29%; I2 = 0%) in anginal episodes and nitroglycerine (NTG) use, respectively. Pooled results also showed an improvement in the physical functioning, angina frequency, treatment satisfaction, and disease perception domains of the Seattle Angina Questionnaire (SAQ). Conclusion: Sham interventions in patients with chronic coronary syndromes were associated with a significant decrease in anginal episodes, NTG use, and CCS angina class and increased SAQ quality of life and exercise time. These results highlight the need for previous non sham-controlled trials to be interpreted with caution, and the importance of new invasive interventions to be evaluated versus a sham procedure.Keywords
This publication has 38 references indexed in Scilit:
- Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancerBMC Medical Research Methodology, 2014
- Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase–bright stem cells in patients with ischemic heart failureAmerican Heart Journal, 2012
- Intramyocardial, Autologous CD34+ Cell Therapy for Refractory AnginaCirculation Research, 2011
- Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trialEuropean Heart Journal, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseNew England Journal of Medicine, 2007
- A randomized, double‐blind, placebo‐controlled, multicenter, pilot study of the safety and feasibility of catheter‐based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery diseaseCatheterization and Cardiovascular Interventions, 2006
- Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectorisThe American Journal of Cardiology, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Angina Pectoris and the Placebo EffectNew England Journal of Medicine, 1979